Loading...
OTCM
ACAI
Market cap0kUSD
Jul 08, Last price  
0.00USD
Jan 2017
-94.67%
IPO
-100.00%
Name

Safeplus International Holdings Ltd

Chart & Performance

D1W1MN
OTCM:ACAI chart
P/E
P/S
EPS
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
-10.08%
Revenues
0k
000075,00001,044,861989,52911,685,684677,92700000
Net income
-19k
L-69.69%
-5,001-729,130-3,705,917-3,438,252-3,718,570-5,793,547-14,315,029-17,722,411-5,177,891-17,069,103-2,652-2,652-47,796-61,127-18,530
CFO
0k
02,092-2,649,744-2,301,884-2,526,860-4,874,854-7,746,646-9,789,9114,712,404-3,431,122-2,652-6,71300

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Safeplus International Holdings Limited, headquartered in Pittsford, New York, and established in 1963, specializes in developing and bringing to market advanced technological solutions for the medical device sector. Formerly operating as Biophan Technologies, Inc. until its rebranding in September 2020, the company is currently looking for partners to help commercialize its extensive portfolio of patented innovations. These proprietary technologies include biothermal power supplies, pulsewidth modulation designed to significantly improve the functionality of pacemakers and neurostimulators, and patented breakthroughs in photonics and nanomaterials.
IPO date
Feb 02, 2000
Employees
2
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFY
2022‑022021‑022020‑022019‑022018‑02
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT